Kumpanart Sundaravibhata

Antinol® Latest Studies

Sorted by recent

What’s better than fun? Double the fun! That’s exactly what 22Fun delivers with its incredible mix of games and opportunities. Whether you’re spinning the reels on slots or trying your hand at a live casino table, 22fun guarantees non-stop entertainment. This platform knows how to keep players smiling with its engaging design and rewarding features. Why just play when you can truly have fun with every bet?

Filter Studies by Smart Tags

Bone & JointCardiovascularCase Study & ProceedingCatDogEAB 277™EfficacyExotic PetImmunologyNeuro & BehaviorOphthalmologyOralRabbitRenalRespiratoryRodentSafetySkinUTI

This trial included 66 mixed breed dogs with x-ray confirmed OA split into two treatment groups for 24 weeks. These were 1) PCSO-524 (5 mg/kg) and 2) fish oil (2,000 mg/d). The dogs were all placed on a standardised diet to minimise variability.

The results suggest that PCSO-524 is protective against cartilage breakdown in dogs with osteoarthritis.

. . . VIEW

. . . VIEW

Application of the Polyunsaturated fatty acid compound PCSO-524 in the post operative recovery of dogs that have had stifle surgery

WSAVA FASAVA Congress 2013
World Small Animal Veterinary Assoc.
38th Annual Congress 6-9 March 2013, Auckland, New Zealand

The clinical outcomes of the use of PCSO-524 in 28 dogs that had undergone surgery on the stifle (which included correction of the patellar luxation and correction of cranial cruciate ligament rupture) were studied at the Small Animal Teaching Hospital, at Chulalongkorn University, Bangkok, Thailand.

Twenty-eight dogs that undergone both stifle surgery were included in our study. All test subjects had been given pre-emptive analgesia (morphine sulfate). NSAIDs and glucosamine had been administered before the surgery.

Two postoperative treatments were:

  1. NSAIDs treatment for one week in combination with glucosamine sulfate;
  2. only PCSO-524 treatments.

 

 

. . . VIEW

 

. . . VIEW

The clinical outcome of PCSO-524 application in the treatment of canine osteoarthritis and spinal disorder was studied at the Small Animal Teaching Hospital, Chulalongkorn University.

Eighty-four dogs were included in our study. Thirty-one dogs showed signs of osteoarthritis (OA) in both hip joints and shoulder joints; 33 dogs had OA in stifle joints from cranial cruciate ligament rupture; and 20 dogs had neurological signs of the cauda equina syndrome.

All affected dogs were treated by 50 mg/ 10 kg of PCSO-524, PO for twelve weeks.

 

. . . VIEW

. . . VIEW

Updated Study Topics

New researches and publications related to PCSO-524® and its result in clnical test submitted by veterinarians on the global conferences every year and the data keeps growing with more studies conducted

 

Discover More Studies
Click to see the library